Newsroom | 45593 results
Sorted by: Latest
-
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...
-
Aegis Sciences Names Joel Galanter Interim CEO
NASHVILLE, Tenn.--(BUSINESS WIRE)--Aegis Sciences Corporation (“Aegis” or the “Company”) today announced it has named Joel Galanter Interim CEO, replacing Frank Basile who served as the company’s CEO since 2017. With more than a decade in senior executive leadership at Aegis, Galanter brings deep institutional knowledge and broad experience across the Company's operations, regulatory environment, and strategic priorities. Galanter has directly overseen the Company's legal, regulatory, governmen...
-
bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath® Lung
SAN ANTONIO, Texas--(BUSINESS WIRE)--bioAffinity Technologies reported second quarter 2026 financial results and continued commercial momentum for CyPath® Lung test for lung cancer....
-
CareTrust Announces $291 Million of Recent Investments; $1.5 Billion Investments Year-To-Date; Reloaded Pipeline
DANA POINT, Calif.--(BUSINESS WIRE)--CareTrust Announces $290 Million of Recent Investments; $1.5 Billion Investments Year-To-Date; Reloaded Pipeline...
-
American Healthcare REIT Announces Second Quarter 2026 Results; Increases Full Year 2026 Guidance
IRVINE, Calif.--(BUSINESS WIRE)--American Healthcare REIT, Inc. (NYSE: AHR) (the “Company,” “we,” “our,” “us,” “management,” or "AHR") is announcing today its second quarter 2026 results and increasing full year 2026 guidance. Key Highlights: Reported GAAP net income attributable to controlling interest of $30.6 million, or $0.16 per diluted share, for the three months ended June 30, 2026. Reported Normalized Funds From Operations attributable to controlling interest (“NFFO”) of $0.54 per dilut...
-
Covista Announces Fiscal Year 2026 Results, Exceeds Financial Guidance; Initiates Fiscal Year 2027 Guidance
CHICAGO--(BUSINESS WIRE)--Covista Inc. (NYSE: CVSA), America’s largest healthcare educator, today reported fourth quarter and fiscal year 2026 results (ended June 30, 2026). The Company completed its three-year Growth with Purpose strategy and now embarks on its Purpose at Scale strategy, leading the transformation of higher education by training the next generation of healthcare professionals at an industry-leading scale. "We completed Growth with Purpose in a position of strength, exceeding b...
-
Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the second quarter ended June 30, 2026. The Company also raised its full-year guidance. Second Quarter Financial Results Revenue of $351.8 million, up 2% year-over-year. Residents served ended the quarter at approximately 210,000, up 8% year-over-year. Net Income of $22.1 million, inclusive of an $8.5 m...
-
Doximity Announces Fiscal 2027 First Quarter Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2027 first quarter ended June 30, 2026. “We're proud that our clinical AI assistant, Doximity Ask, was the top-performing U.S.-based model in the NOHARM benchmark while we delivered another quarter of record engagement,” said Jeff Tangney, co-founder and CEO of Doximity. "In Q1 we had accelerated revenue growth along with workflow active...
-
ModMed and IntrinsiQ Specialty Solutions Form Strategic Alliance to Deliver Software Solutions to IntrinsiQ Customers
BOCA RATON, Fla.--(BUSINESS WIRE)--ModMed, a leading provider of software and services to specialty medical practices, today announced a collaboration with IntrinsiQ Specialty Solutions (IntrinsiQ), establishing ModMed as the preferred go-forward provider of electronic health records (EHRs) for IntrinsiQ’s UroChartEHR® customers. ModMed is now part of IntrinsiQ’s Trusted Vendor Program, a portfolio of cutting-edge operational and clinical care solutions. IntrinsiQ connects member practices with...
-
OneLegacy Sets New Record for Organs Transplanted
LOS ANGELES--(BUSINESS WIRE)--OneLegacy, the organ, eye, and tissue procurement organization serving seven counties in Southern California since 1977, set a new monthly record for July, enabling the transplantation of 210 lifesaving organs, thanks to the generosity of 71 donors and their families, and the expert coordination of dedicated medical teams. This milestone reflects the strength of collaboration across Southern California's donation and transplantation community. Working around the cl...